$MIST 8-K SEC Filings

Filed On	Filing
28 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On October 23, 2026, Milestone Pharmaceuticals Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common shares was no...
03 Sep 2026	8-K: Other Events
12 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
13 May 2026	8-K: Results of Operations and Financial Condition
20 Mar 2026	8-K: Results of Operations and Financial Condition
26 Jan 2026	8-K: Other Events
13 Jan 2026	8-K: Other Events
06 Jan 2026	8-K: Other Events
15 Dec 2025	8-K: Regulation FD Disclosure; Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
12 Aug 2025	8-K: Results of Operations and Financial Condition
14 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events
11 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events
16 Jun 2025	8-K: Other Events
12 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
14 May 2025	8-K: Results of Operations and Financial Condition
28 Mar 2025	8-K: Other Events
19 Mar 2025	8-K: Shareholder Director Nominations
18 Mar 2025	8-K: Entry into a Material Definitive Agreement; Other Events

Comments